SLC5A2 and diabetic kidney disease: Clinical studies have found that the combination of cordyceps preparations (BLC) with ACEI/ARB or SGLT2 inhibitors could significantly reduce the excretion of urinary protein, alleviate kidney damage, and delay the progression of DKD compared with the use of ACEI/ARB or SGLT2 inhibitors alone (Li Z. et al., 2019b; Li and Gao, 2021).